SpaceX Successfully Launches Starship on Second Attempt Advancing Reusable Rocket Development Fed Dissenters Object to RateCut Signal in PostMeeting Statement Bessent Predicts Substantial Disinflation Ahead as Warsh Set to Lead Fed Jim Cramer Explores Link Between Dollar General DG and Iran Tensions China Emerges as Leading Competitor in Humanoid Robotics Race Says Teslas Musk Rising Gas Prices Drive Interest in FuelEfficient Trucks Ford Maverick Hybrid and Ram 1500 Lead the Way NCTY Q1 2012 Earnings Narrower Loss Than Expected as Revenue Picture Remains Unclear Integra Resources ITRG Q1 2026 Earnings EPS Falls Short of Expectations Amid Exploration Focus Danaos Corporation DAC Q1 2026 Earnings EPS Falls Slightly Short Amid Market Adjustments CMBT Q1 2026 Earnings EPS Surges Past Estimates as Operational Efficiency Drives Profitability Northpointe Bancshares Inc NPB Q1 2026 Earnings EPS Misses Estimates Shares Dip in First Report as Public Company CVGI Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment Cardinal Infrastructure Group Inc CDNL Gains 34 as Infrastructure Demand Strengthens AMSC Faces Resistance After Sharp Decline Key Levels to Watch Western Union WU Slips 15 Testing Key Support Amid Digital Disruption Concerns Twilio TWLO Slips 43 as Selling Pressure Intensifies Support at 172 in Focus CapsoVision Inc CV Advances 118 as Price Moves Toward Resistance Green Bay Packers Face Critical Roster Cuts Financial and Strategic Implications MOB Q4 2025 Earnings Widening Losses Surprise Markets Yet Shares Rally Mesa Royalty Trust MTR Stages a 455 Rebound Key Levels in Focus INNV Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines The Late Show With Stephen Colbert Finale Signals Shift in LateNight Television Landscape Broadcom Meta and Industry Giants Invest 125 Million in UCLA Semiconductor Research Hub SRE Q1 2026 Earnings EPS Misses Estimates by 137 as Regulated Growth Offsets Headwinds UK Inflation Drops to 28 but Analysts Warn of Potential Rebound QBTS Q1 2026 Earnings EPS Surprise Stuns Analysts Shares Surge Over 33 Marker Therapeutics Q1 2026 Earnings Loss Narrows as Clinical Progress Continues